Reduced-dose CT Determines Intervention in Urologic Patients
CT, with lower radiation dose, can help emergency room physicians determine which patients with ureteral stones need further intervention.
A reduced-dose CT protocol can help identify patients with moderate to high likelihood of ureteral stones who may require urologic intervention, according to a study published in Radiology.
Researchers from Connecticut, Virginia, and California performed a prospective study to determine if a reduced-dose CT protocol could effectively help to identify patients in the emergency department with moderate to high likelihood of calculi who would require urologic intervention within 90 days.
The researchers used previously derived and validated STONE clinical prediction rule of five elements: sex, timing, origin, nausea, and erythrocytes. Patients who scored a high STONE score (STONE score, 10–13) underwent reduced-dose CT, while those with moderate likelihood of ureteral stone (moderate STONE score, 6–9) underwent reduced-dose CT or standard CT based on clinician discretion. The patients were followed for up to 90 days after initial imaging for clinical course and for the primary outcome of any intervention.
A total of 264 participants enrolled in the study and 165 reduced-dose CTs were performed; 108 patients underwent reduced-dose CT alone with complete follow-up. Overall, 46 of 264 (17.4%) of patients underwent urologic intervention, and 25 of 108 (23.1%) patients who underwent reduced-dose CT underwent a urologic intervention; all were correctly diagnosed on the clinical report of the reduced-dose CT. The average dose-length product for all standard-dose CTs was 857 mGy · cm ± 395 compared with 101 mGy · cm ± 39 for all reduced-dose CTs (average dose reduction, 88.2%). The researchers noted that there were five interventions for nonurologic causes, three of which were urgent and none of which were missed when reduced-dose CT was performed.
The researchers concluded that a CT protocol with over 85% dose reduction can be used in patients with moderate to high likelihood of ureteral stone to safely and effectively identify patients in the ED who will require urologic intervention.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
